Evidence map›Paper›PMID 36178430›Full record

ArticleTransfusion2022

Assessment of polymicrobial interactions in bacterial isolates from transfused platelet units associated with sepsis.

Christopher A Kerantzas, Jacob Merwede, Edward L Snyder, Jeanne E Hendrickson, Christopher A Tormey, Barbara I Kazmierczak, David R Peaper

Open access · greenAbstract read
In one paragraph

Article in Transfusion, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Alterations in RNA Expression Profile FollowingInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Christopher A KerantzasDepartment of Laboratory Medicine, Yale University, New Haven, Connecticut, USA.ORCID 0000-0002-6745-9452
Jacob MerwedeDepartment of Laboratory Medicine, Yale-New Haven Hospital, New Haven, Connecticut, USA.
Edward L SnyderDepartment of Laboratory Medicine, Yale University, New Haven, Connecticut, USA.
Jeanne E HendricksonDepartment of Laboratory Medicine, Yale University, New Haven, Connecticut, USA.ORCID 0000-0002-7928-3132
Christopher A TormeyDepartment of Laboratory Medicine, Yale University, New Haven, Connecticut, USA.ORCID 0000-0003-1785-2245
Barbara I KazmierczakDepartment of Internal Medicine, Section of Infectious Disease, Yale University, New Haven, Connecticut, USA.
David R PeaperDepartment of Laboratory Medicine, Yale University, New Haven, Connecticut, USA.
Yale University · USYale New Haven Hospital · US

Funding

IMMUNOHEMATOLOGY/TRANSFUSION MEDICINE RESEARCH TRAININGT32HL007974 · NHLBI · YALE UNIVERSITY · PI JEANNE E HENDRICKSON, Diane S Krause · 2001 to 2026
$8.1M
NHLBI NIH HHS T32 HL007974
6 · The paper itself

Abstract

backgroundIn 2019 the Centers for Disease Control and Prevention (CDC) reported a series of 4 transfusion reactions that resulted from contamination of apheresis platelet products. Products involved in all 4 cases were contaminated with Acinetobacter calcoaceticus-baumannii complex (ACBC) and in 3 products Staphylococcus saprophyticus was found as well. CDC investigation found that bacterial isolates from the cases were genetically related and suggested a common source of contamination. The contamination of blood products with ACBC is rare and polymicrobial contamination of blood products even less common. ACBC and S. saprophyticus have been observed to adhere to one another and sediment out of suspension in vitro, a process referred to as coaggregation, and we hypothesized that there was an interaction between the strains from these cases that contributed to their co-contamination of blood products. STUDY DESIGN AND

methodsTo test the hypothesis of bacterial interaction, we performed coaggregation experiments and observed the growth characteristics of ACBC and S. saprophyticus strains recovered from contaminated blood products involved in a subset of the CDC cases.

resultsAn increase in S. saprophyticus CFU concentration was observed after several days of co-culture with ACBC in LB and plasma; however, no other findings suggested coaggregation or augmentative growth interaction between the bacterial strains.

conclusionUltimately, an interaction between ACBC and S. saprophyticus that could help explain their co-occurrence and growth in contaminated platelet units was not found; however future studies of potential interactions may be warranted.

Indexed as

Centers for Disease Control and Prevention, U.S.HumansUnited States

Identifiers

PMID36178430
PMCPMC11472026
OpenAlexW4298086867

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.